Finasteride: The Trade-Off Nobody Explains Clearly
It is one of the two medicines that actually slow a receding hairline, and it has a sexual side-effect story that is both smaller than the forums and larger than the original brochure. How to think about it before a compounding pharmacy writes 1 mg.
Finasteride 1 mg is not a vitamin. It is a 5-alpha reductase inhibitor that lowers dihydrotestosterone, which is the hormone a genetically susceptible follicle is listening to. That is why it works, and it is why the side-effect conversation exists.
Brazilian men often meet the drug as a compounded capsule in a "kit" with minoxidil, sometimes without anyone saying the word trade-off. The trade-off is the whole decision.
General educational information, not medical advice. Do not start, split or stop a prescription from a forum table. If you are trying to conceive, tell the clinician before anyone writes the script.
What the trials actually showed
In the original male-pattern-baldness trials, a minority of men on 1 mg reported reduced libido, erectile difficulty or a change in ejaculation — on the order of about 2% above placebo in the older datasets, with most of those reports resolving on stopping, and some resolving on continuing. Later observational work and pharmacovigilance have kept a signal, including mood. The label in several countries now mentions depression and, rarely, suicidal thought.
Two honest sentences can sit together. Most men on 1 mg do not get a sexual side effect. A man who does get one should not be told he imagined it.
"Post-finasteride syndrome" — persistent symptoms after stopping — is reported, poorly defined, and not settled as a mechanism. That uncertainty cuts both ways. It is not a reason to pretend the reports do not exist. It is not a reason to treat a well-studied drug as radioactive.
Dutasteride, topical, and the compounding version
Dutasteride 0.5 mg blocks two isoenzymes rather than one and, in head-to-heads, tends to outperform finasteride on hair counts. ANVISA has approved it for male androgenetic alopecia. The sexual side-effect conversation is not obviously smaller. "Stronger on hair" is not "gentler on the rest".
Topical finasteride is the attempt to keep the scalp effect and lose the systemic one. Blood DHT still falls in some studies; it is not a free lunch. It may be a reasonable option in a man who had a systemic side effect and still wants a 5-alpha reductase inhibitor. It is not a way of taking the drug without having taken the drug.
Compounded 1 mg in Brazil is often cheaper than the originator. Compounding is not the issue. A kit that arrives without a conversation about fertility, PSA (the number falls, and a urologist needs to know), mood, and what you will do if libido drops — that is the issue.
The fertility and PSA footnotes, which are not footnotes
Finasteride can reduce ejaculate volume and, in some men, sperm counts. If you and a partner are trying, or will be in the next year, that is a reason to pause the decision, not a reason to hide the tablet. See male fertility.
PSA falls by roughly half. Tell anyone who is going to order a PSA that you are on it, or the number will be misread.
How to decide without a manifesto
If keeping the hair you have is worth a small, usually reversible sexual risk, and you would stop if the risk showed up, you are in the population the trials were for. If a 2% risk (and a rarer persistent one) is not acceptable, minoxidil alone and, later, a transplant that does not require the drug are the other tools. See how to slow baldness and transplants.
If libido or erection changes after you start, do not add a testosterone booster on top. Come off, wait, and talk to the prescriber. The overlap with low libido and erectile dysfunction is how men end up on three treatments for one drug effect.
Our disclaimer sets out the limits of what this site does.
